Fasoracetam vs Pramiracetam for focus
Short answer: For focus, users rate them about the same: 98% report improvement with Fasoracetam (59 reports) and 95% with Pramiracetam (91 reports).
Fasoracetam has 1 meta-analyses and 0 randomized trials on PubMed; Pramiracetam has 0 and 3.
Based on 279 reports about Fasoracetam and 343 about Pramiracetam. Not medical advice.
| Fasoracetam Supplement | Pramiracetam Supplement | |
|---|---|---|
| Users say it helped | 83%helped112 reports · high confidence | 59%helped127 reports · high confidence |
| Verdict | Mostly positive | Mixed |
| Research | BResearch: Moderate | CResearch: Limited |
| Meta-analyses / RCTs | 1 / 0 | 0 / 3 |
| Mainly used for | ||
| Focus % reporting improvement | 98% (59) | 95% (91) |
| Anxiety % reporting improvement | 94% (49) | 100% (8) |
| Memory % reporting improvement | 87% (15) | 95% (38) |
| Mood % reporting improvement | 100% (18) | 45% (22) |
| Energy % reporting improvement | 100% (10) | 91% (11) |
| Common side effects | drowsiness, headache, tolerance, anorgasmia | headache, emotional blunting, fatigue, bad taste |
| Typical dose reported | 50 mg | 1 teaspoon |
However, they may offer comparable or better tolerability. Additionally, agents acting on etiopathophysiological targets disrupted in specific subgroups of patients with ADHD will move forward the pharmacotherapy of ADHD from a 'one size fits all' to a 'precision medicine' approach.
Expert Rev Neurother, 2019 ↗“the tingle of disassociation and anxiety that lurks at the back of my mind at all times was gone, it felt as though i had finally been released from a prison cell.”
“I was very anxious and listless for a while and the substances that helped me the most were Pramiracetam + alpha GPC.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate